Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110-02 PET Occupancy Study in Healthy Japanese Male Volunteers
jRCT2071230063Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ONO-1110 (3 arms), sponsored by Ono Pharmaceutical. Primary endpoint: Target Molecule Occupancy in the Brain of ONO-1110. Started Nov 2023; status: completed.
02
Drugs
ONO-1110
Beyond the preview
Go deeper on jRCT2071230063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230063.